Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Neoleukin Therapeutics, Inc. (AQXP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/23/2023 |
8-K/A
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 12/17/2019 |
8-K/A
| Financial Statements and Exhibits |
| 10/11/2019 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Audited financial statements of Neoleukin Therapeutics, Inc. as of December 31, 2018 and for the period from June 4, 2018 (inception) through December 31, 2018",
"Unaudited financial statements of Neoleukin Therapeutics, Inc. as of June 30, 2019 and December 31, 2018 and for the six-month period ended June 30, 2019 and for the period from June 4, 2018 (inception) to June 30, 2018",
"Unaudited pro forma condensed combined financial statements as of June 30, 2019 and for the six-month period ended June 30, 2019 and for the year ended December 31, 2018" |
|
| 08/07/2015 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|